Pataday and Aspirin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Pataday (olopatadine hydrochloride) and Aspirin (aspirin). Common drug interactions include migraine among females and cough among males.
The phase IV clinical study analyzes what interactions people have when they take Pataday and Aspirin. It is created by eHealthMe based on reports of 396 people who take the same drugs from the FDA, and is updated regularly.
What is Pataday?
Pataday has active ingredients of olopatadine hydrochloride. It is often used in allergies. eHealthMe is studying from 8,288 Pataday users. Check the latest studies of Pataday.
What is Aspirin?
Aspirin has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 632,089 Aspirin users. Check the latest studies of Aspirin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
396 people who take Pataday and Aspirin together, and have interactions are studied.
What are the common drug interactions of Pataday and Aspirin, by gender? *
What are the common drug interactions of Pataday and Aspirin, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Pataday and Aspirin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Pataday and Aspirin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Pataday:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Aspirin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pataday and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aspirin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
- Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
How the study uses the data?
The study uses data from the FDA. It is based on olopatadine hydrochloride and aspirin (the active ingredients of Pataday and Aspirin, respectively), and Pataday and Aspirin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Keflex vs. Dicloxacillin Sodium, side effect and effectiveness comparison - 15 seconds ago
- Could Miralax cause Intestinal Functional Disorder? - 21 seconds ago
- Cyanocobalamin and Xeljanz Xr drug interactions for women aged 50-59 - 24 seconds ago
- Could Pregabalin cause Idiopathic Pulmonary Fibrosis? - a minute ago
- Could Retin-A cause Thrombocytopenia? - a minute ago
- Drug interactions of Osmoprep and Profen - a minute ago
- Sepsis and drugs of ingredients of isotretinoin - a minute ago
- Could Accutane cause Septic Shock? - a minute ago
- Could Enoxaparin Sodium cause Oral Pain? - a minute ago
- Could Solu-Medrol cause Streptococcal Sepsis? - a minute ago